Leem adds board members
This article was originally published in Scrip
Leem, the French pharmaceutical industry association, has made Jean Scheftsik de Szolnok, president of Boehringer Ingelheim France, a member of its board of directors. Dr Robert Dahan, CEO of AstraZeneca France has become a vice-president, and Dr Patrice Zagamé, CEO of Novartis France, has been made an officer. The appointees will replace Dominque Mangeot on the board.
You may also be interested in...
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.